{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-269514","form_type":"8-K","ticker":null,"cik":"0001445499","company_name":"IMPEL PHARMACEUTICALS INC","filed_at":"2023-11-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.097350+00:00","generated_at":"2026-06-08T23:54:47.427714+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Impel Pharmaceuticals CEO Adrian Adams resigns; CCO Len Paolillo named interim CEO","bullets":["Adrian Adams resigned as Chairman, President and CEO effective Nov. 4, 2023; no disagreement cited.","Leonard S. Paolillo, current Chief Commercial Officer, appointed Interim President and CEO.","Paolillo joined Impel in March 2021; previously EVP & CCO at Kyowa Kirin North America.","Board to formally appoint Paolillo upon Adams's departure."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-269514","json":"https://secwatch.observer/filing/0001193125-23-269514.json","markdown":"https://secwatch.observer/filing/0001193125-23-269514.md","text":"https://secwatch.observer/filing/0001193125-23-269514.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1445499/000119312523269514/0001193125-23-269514-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1445499/000119312523269514/d397416d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T23:54:47.427714+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"65e17bc7b2","claim":"Adrian Adams resigned as Chairman of the Board, President and Chief Executive Officer at IMPEL PHARMACEUTICALS INC.","evidence_excerpt":"On October 29, 2023, Adrian Adams gave notice of his resignation from his position as Chairman of the Board and as President and Chief Executive Officer of Impel Pharmaceuticals Inc. (the “ Company ”) effective November 4, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1445499/000119312523269514/0001193125-23-269514-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chairman of the Board, President and Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"6cd35d5e94","claim":"Leonard S. Paolillo was appointed as Interim President and Chief Executive Officer at IMPEL PHARMACEUTICALS INC.","evidence_excerpt":"The Board of Directors of the Company intends to appoint Leonard S. Paolillo as Interim President and Chief Executive Officer effective upon Mr. Adams’s resignation.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1445499/000119312523269514/0001193125-23-269514-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Interim President and Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}